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This study applied a deep-learning cell identification algorithm to diagnostic images
from the colon cancer repository at The Cancer Genome Atlas (TCGA). Within-image
sampling improved performance without loss of accuracy. The features thus derived were
associated with various clinical variables including metastasis, residual tumor, venous
invasion, and lymphatic invasion. The deep-learning algorithm was trained using images
from a locally available data set, then applied to the TCGA images by tiling them,
and identifying cells in each patch defined by the tiling. In this application the average
number of patches containing tissue in an image was ∼900. Processing a random
sample of patches greatly reduced computation costs. The cell identification algorithm
was applied directly to each sampled patch, resulting in a list of cells. Each cell was
labeled with its location and classification (“epithelial,” “inflammatory,” “fibroblast,” or
“other”). The number of cells of a given type in the patch was calculated, resulting
in a patch profile containing four features. A morphological profile that applied to the
entire image was obtained by averaging profiles over all patches. Two sampling policies
were examined. The first policy was random sampling which samples patches with
uniform weighting. The second policy was systematic random sampling which takes
spatial dependencies into account. Compared with the processing of complete whole
slide images there was a seven-fold improvement in performance when systematic
random spatial sampling was used to select 100 tiles from the whole-slide image
for processing, with very little loss of accuracy (∼4% on average). We found links
between the predicted features and clinical variables in the TCGA colon cancer data
set. Several significant associations were found: increased fibroblast numbers were
associated with the presence of metastasis, venous invasion, lymphatic invasion and
residual tumor while decreased numbers of inflammatory cells were associated with
mucinous carcinomas. Regarding the four different types of cell, deep learning has
generated morphological features that are indicators of cell density. The features are
related to cellularity, the numbers, degree, or quality of cells present in a tumor.
Cellularity has been reported to be related to patient survival and other diagnostic
and prognostic indicators, indicating that the features calculated here may be of
general usefulness.
Keywords: sampling, histopathology, TCGA, morphology, colon cancer, deep learning
Shapcott et al. Sampling for Colon Cancer Histology Images
INTRODUCTION
Histopathology, the microscopic examination of diseased tissue
is central to the diagnosis and treatment of cancer. Recent
developments in digital microscopy have enabled the extraction
of useful information from whole-slide images (WSIs) of
cancer tissue using deep learning algorithms that are based
on convolutional neural networks (Janowczyk and Madabhushi,
2016). Ideally, deep learning applications can replace tasks
carried out in manual pathology, identifying key features that are
easily interpretable and that have prognostic power.
Most deep learning algorithms are trained with relatively
small images. To apply a trained algorithm to a whole-slide
image a straightforward approach is to tile the WSI with small
patches and apply the deep-learning algorithm to each patch
independently. The per-patch results may be averaged over the
WSI to generate a collection of features which characterize the
spatial characteristics of the WSI, amorphological profile.
However, such an approach is computationally costly: on
average, each WSI in the data set used in this study contained
about 900 patches that had significant amounts of tissue.
Computational costs can be reduced by sampling a limited
number of patches, applying the algorithm to each, then
averaging the per-patch features. In principle, if enough patches
are sampled, processing costs can be reduced without significant
loss of accuracy. The main aim of this study was to examine
the behavior of sampling as applied to WSIs. In addition, we
have showed how profiles generated by sampled patches have
significant associations with clinical variables.
Figure 1 illustrates the stages used to create a morphological
profile from a whole-slide image. The cell identification
algorithm has been trained using images of fixed size and
resolution. (In the experiments described here, the training
image size was 500 × 500 pixels at a resolution of 20X, ∼0.5
microns/pixel). The algorithm identifies cells (in practice cell
nuclei) and classifies them as one of four types (epithelial cells,
inflammatory cells, fibroblasts, and “other” cells).
FIGURE 1 | From image to profile: stages. (A) Histopathology Image. (B) Foreground Mask. (C) Tiling, with sampled patches. (D) Sampled patch. (E) Cells identified
by algorithm. (F) Histogram of cell frequencies.
In the first stage, that of segmentation, the whole slide
image (1a) is separated into foreground and background regions,
represented by a binary mask (1b). In the second stage the mask
is divided into patches which are the same size and resolution as
those used to train the algorithm. Each patch then is categorized
as foreground or background, depending on the percentage of
pixels assigned by the mask. Next, as shown in (1c) foreground
patches in the grid of tiles are sampled. For each patch (1d)
that has been sampled the cell identification algorithm locates
and classifies cells (1e). The information concerning cell nuclei
is summarized in a tile profile. The tile profiles are averaged,
generating the profile for the whole-slide image. The profile is
displayed as a histogram (1f) showing the frequencies of the four
cell types: epithelial, inflammatory, fibroblasts and “other.” The
features comprising the profile can be interpreted as measures of
cellularity, the number of cells of a given type in the cancer tissue.
Cellularity is described as:
“The degree, quality, or condition of cells that are present”
(Farlex Partner Medical Dictionary, 2012).
Sampling of regions within an image is a standard procedure
in manual pathology. Pathologists are accustomed to rapidly
scanning tissue slides under the microscope and selecting
interesting regions for intensive consideration. Kayser et al.
(2009) discuss how an equivalent procedure can be carried out
using digital pathology. They propose an implementation using
three stages. In the first stage a set of regions in the image
is generated by automated sampling, in the second stage an
information measure is calculated for each region, and in the
final stage the most informative regions are selected for intensive
consideration by the pathologist. The authors argue that this
hybrid approach can achieve viewing times that are comparable
with those achieved in manual pathology.
Automated sampling within an image is used in stereology,
originally the analysis of three-dimensional structures, using two-
dimensional sections. In stereology various statistical procedures
are used to extract significant structural information. A typical
approach is to lay a regular grid over the image, and to sample
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the image using the grid. Stereology has been applied using digital
pathology by Keller et al. (2013). The authors found that the use
of their automated sampling algorithm was 50–90% more time
efficient than conventional random sampling.
In another study sampling was employed in the analysis
of cases of colon cancer where pathologists were asked to
categorize the tissue type at 300 randomly selected points in
a dense region of tissue (West et al., 2010). The study found
that a low proportion of tumor cells was related to poor cancer-
specific survival.
As for digital pathology, a description of the use of sampling in
the detection of invasive breast cancer in histopathology images
can be found in Cruz-Roa et al. (2018). A trained CNN classifier
accepted patches of fixed size as input. The pathology image was
tiled and in the first sampling step the resulting patches were
randomly sampled. Each patch in the sample set was classified as
homogeneous or heterogeneous. Regions of interest were those
where the classification was uncertain. The regions surrounding
tiles of uncertain classification were searched by sampling them
systematically, using the gradient of the uncertainty map to guide
the search.
In histopathology applications the choice of a sampling policy
is affected by spatial dependency, whereby characteristics at
neighboring locations tend to have similar values. Standard
statistical sampling techniques that assume independence among
observations do not take spatial dependency into account
and are not always the most appropriate. Sampling policies
that do take account of spatial dependencies have been
developed in geospatial statistics (Delemelle, 2009) and of
these systematic random sampling is a well-known technique
(De Smith, 2018).
In the experiments described in this article a straightforward
approach has been used: sampling of a set of patches, followed
by cell identification, and profile generation. The two sampling
policies that have been implemented are random sampling, and
systematic random sampling.
Note that in some situations, non-random sampling, such as
uniform spacing may be adequate. Uniform spacing gives good
coverage of the WSI but will fail if there are periodicities in the
image, or if there are relationships that depend on distance that
should be estimated from the sample.
In the work described here, variants of two sampling policies
have been implemented. In the basic form of Random Sampling
(RS) a set of N points is selected from a W × H sized rectangle,
using the uniform distribution over [W, H]. Random sampling
is straightforward to implement but if spatial dependencies are
present random sampling tends over-sample some areas and
under-sample others.
Systematic Random Sampling (SRS) overcomes the
unbalanced sampling problem of RS. The region surrounding
the image is overlaid with a grid of identical tiles and a sample is
taken from within each tile. SRS may be viewed as a combination
of random and non-random sampling.
In adaptive sampling, information is derived from the samples
already taken, and used to choose later samples. If elements of
search are incorporated into the sampling process, then adaptive
sampling may be appropriate. SRS and RS are non-adaptive
sampling policies: all observations are made at once, according
to the same rule.
This article reports on experiments with sampling polices, RS
and SRS. Because there was no prior information to indicate
that any specific feature in the morphological profile should be
prioritized, we did not consider the use of adaptive sampling.
This does not rule out the use of adaptive sampling in future
applications, for example, when it is necessary to concentrate
on features that are uncommon and when sampling should
be directed toward areas with such features. For example, if a
tissue sample consists mainly of normal cells, but we wish to
analyze the features of abnormal cells, it might be advisable to
search near points already sampled that were found to contain
abnormal cells.
MATERIALS AND METHODS
Cell Identification Algorithm
To enable the comparison of the two sampling policies in
the calculation of WSI profiles a cell identification algorithm
was trained, based on work described in Sirinukunwattana
et al. (2016). The algorithm comprised two convolutional neural
networks (CNNs) working in series. The first network was
a detection network which located cells and passed the cell
coordinates to the second network, a classification network which
categorized each cell as epithelial, inflammatory, a fibroblast or
as “other.” The algorithm was trained using a dataset augmented
from that used in Sirinukunwattana et al. (2016). Training data
was a set of RGB images of size [500 × 500] at 20X. The output
of the cell identification algorithm was a cell map—a set of cell
locations and cell types.
In equation (1) the model accepts an image I, and creates a
cell-map consisting of nM cell nuclei, located at points <x,y>
each of which is labeled by a cell type c.
M (I) = {nM , xi, yi, ci : 1 ≤ i ≤ nM}# (1) (1)
The image’s morphological profile is a set of J features. Feature
fj is the number of cells of type j in the cell map:
fj =
nM∑
i
{
(ci} == j
)
# (2) (2)
Figure 2 displays a patch marked with the results of the
cell identification algorithm (500 pixels square at 20X). The
algorithm has identified a mixture of epithelial cells (red dots)
and inflammatory cells (green dots), plus cells identified as
fibroblasts (yellow dots). To compute the morphological profile
of the patch, we simply count the numbers of different types
of cell.
Training the Cell Identification Algorithm
Training data consisted of 853 hand-marked images, most of
which were from the same WSIs described in Sirinukunwattana
et al. (2016). The detection algorithm was trained using the
method proposed in that publication and described there. The
code was implemented in Matconvnet (Vedaldi and Lenc, 2015).
The same clustering algorithm as detailed in Sirinukunwattana
et al. (2016) was applied to the probability map output by the
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FIGURE 2 | Patch showing types of cells identified.
convolutional neural network and generated the locations of
cell nuclei.
The classification model, based on the Tensorflow “cifar10”
model (Krizhevsky, 2009), was trained with Tensorflow (Abadi
et al., 2016), using the Pycharm IDE. The layers of the
classification CNNwere the same as those defined in the “cifar10”
model (Tensorflow, 2018), and the following hyperparameters
were applied: (batch size = 128, moving average decay = 0.9999,
number of epochs per decay = 350, learning rate decay factor
= 0.1, initial learning rate = 0.1, maximum number of steps
= 1,000,000).
The training data used in classification was marked with
the locations of different types of cells. The data set included
the 100 training images described in Sirinukunwattana et al.
(2016) plus patches from the same WSIs and new ones. Sub-
patches for training the classification network were generated
by selecting 51 × 51 pixel images around hand-marking points.
There were 111,659 of these, from which smaller patches of size
33 × 33 pixels were extracted subject to random displacements
that allowed for inaccuracies in location (an average of up
to ±5 pixels) and each which was augmented in training by
four extra images generated by rotation and reflection. All
processing was done at 20X (0.5microns/pixel). The average RGB
intensities of the training patches were recorded for later use in
standardization. An accuracy of 84% was achieved in evaluation
of classification using a hold-out set.
Experimental Dataset
Colorectal cancer data from The Cancer Genome Atlas (TCGA)
has yielded a molecular characterization of human colon and
rectal data (Cancer Genome Atlas Network, 2012).With a view to
the creation of image profiles, diagnostic images of colon cancer
(from haemotoxilyn and eosin formalin embedded samples) were
downloaded from the TCGA COAD data set, via the Genomic
Data Commons Portal (2018)1 COAD, the TCGA colon cancer
dataset, contains 400+ diagnostic images, stored in SVS format,
most of which have a resolution of 40X (0.25 microns/pixel). Of
the COAD set 142 images were selected from a single site, the
“AA” site.
Implementation of Profile Generation
Segmentation
Each WSI was segmented into foreground (tissue present) and
background (no tissue present) regions using an entropy-based
algorithm which created a foregroundmask (See Figure 1B). The
WSI was tiled with square patches 500 pixels in width (20X).
Patches that overlapped with the foreground mask were denoted
as foreground patches.
Random Sampling—Cell Identification
In the case of RS and for each experimental run, nT patches were
randomly sampled from the set of nF foreground patches. The
cell detection algorithm was applied to each patch individually.
The detection component calculated the haemotoxylin channel
and supplied it to the detection CNN. The classification module
extracted small patches around each detected point, normalized
them collectively, using the average intensities saved from the
training stage, and applied the classification algorithm to each
patch individually, generating a set of patch types which were
used to calculate morphological profiles.
Denoting the profile of patch t by ftij, where each WSI is
labeled with index i the whole-slide profile fwij is:
fwij =
∑nT
t=1 ftij
nT
# (3) (3)
Systematic Random Sampling—Cell
Identification
The following version of SRS was implemented. As with RS a
sample size was specified: in this case a nominal sample size
nNOM. A coarse tiling of the WSI used sample grids, squares
that each contained g × g patches. With SRS one patch was
sampled randomly from each sample grid. If the tile was a
foreground tile, then the cell identification algorithm was applied
to the patch and the resulting profile was added to a list of
profiles associated with the WSI. Otherwise, if the patch was a
background patch, it was ignored. The whole-slide profile was
calculated by averaging the profiles in the list. The choice of g,
the dimension of the sample grid, depended on the number of
foreground tiles in the image as well as on the nominal sample
size. The size of the sample grid is a function of three quantities,
nNOM, the minimum number of tiles to be sampled; γ, the
fraction of tiles in the image that are not artifacts; and nF the
number of foreground tiles,
g = floor
(√
γ nF
nNOM
)
# (4) (4)
1https://gdc.cancer.gov
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FIGURE 3 | Detail of whole-slide image showing sample grids and selected patches.
Figure 3 is a detail of a whole slide split into sample grids
with divisions indicated by blue lines. Each sample grid contains
3 × 3 tiles. The tiles selected by SRS for processing by cell
identification are outlined in yellow. Not every sample grid in the
figure contains a yellow square: if the sample grid contains only
background tiles no tile will be selected; or if a background tile
happens to be selected then it is not processed.
Note that a straightforward gray-detection algorithmwas used
to identify patches containing artifacts. The percentage of patches
containing artifacts γ was estimated by sampling patches.
Evaluation of Profile Generation
In five of the TCGA diagnostic images 1,500 cells were
hand-marked by a pathologist. Cells were classified as normal
epithelial cells, malignant epithelial cells, inflammatory cells or
as fibroblasts. Patches containing hand-marked cells were run
through the cell identification algorithm, and the accuracies
of detection and classification were computed. (Note that the
two types of epithelial cells were merged into one, because
the cell identification algorithm did not distinguish them).
Both detection and classification achieved 65% accuracy on
average (Table 1).
Experiments With Sampling
Both sampling policies, RS and SRS, were applied using the
following nominal sample sizes: 25, 50, 100. For both RS and SRS
and for each nominal sample size two batch runs were executed.
In each batch run the sampling policy was applied to the 142
whole slide images. The batch runs of RS were done after those
for SRS using the actual sample sizes generated by SRS, ensuring
that the runs could be compared for accuracy.
Figure 4 comprises four scatterplots. Each scatterplot displays
results for one type of cell and each point on a scatterplot
corresponds to one of the images from the experimental dataset.
X values are profile features calculated in the first batch run and
TABLE 1 | Detection and classification accuracy.
Patient ID Detection accuracy Classification accuracy
AA-3543 0.85 0.66
AA-3845 0.68 0.76
AA-3864 0.62 0.81
AA-3986 0.61 0.90
AA-A02J 0.50 0.66
Average 0.65 0.76
Y values are the corresponding features output by the second
batch run.
Table 2 compares SRS and RS for a range of sample sizes and
cell types. Table entries have been computed as follows. For a
given nominal sample size, cell type, and WSI, the difference
between the features output by two batch runs is calculated.
The absolute difference is taken, averaged over all 142 images,
and divided by the global average for that cell type to create a
relative batch difference. As would be expected, the relative batch
difference decreases with increasing sample size. SRS performs
better than RS in all cases. For example, for epithelial cells, SRS
average relative batch differences are fractions 0.80, 0.74, and 0.60
of the corresponding RS values.
Correlation Matrix
Table 3 shows the correlations between counts of the four
types of cells. A-priori one might expect cell counts to be
negatively correlated because cells are competing for space in
the tissue. Of the six correlations in the lower left of the
matrix four are negative: however, the number of fibroblasts is
positively related to the number of “Other” cells. Possibly, the
algorithm is misidentifying cells here, or there may be a genuine
biological connection.
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FIGURE 4 | Scatterplots comparing batch runs of SRS (systematic random sampling).
TABLE 2 | Comparison of RS and SRS.
Sample size (Nominal number of tiles) 25 50 100
Epithelial cells Global average (per 100 micron square): 21.3 cells
RS–relative batch diff. 11.30% 8.10% 5.80%
SRS–relative batch diff. 9.20% 6.00% 3.50%
Inflammatory cells Global average: 5.52 cells
RS–relative batch diff. 19.20% 12.50% 8.30%
SRS–relative batch diff. 17.40% 7.60% 6.50%
Fibroblasts Global average: 5.64 cells
RS–relative batch diff. 14.50% 11.00% 8.00%
SRS–relative batch diff. 13.80% 8.10% 4.80%
“Other” cells Global average: 2.43 cells
RS–relative batch diff. 24.30% 16.90% 9.90%
SRS–relative batch diff. 20.10% 11.50% 7.80%
MORPHOLOGICAL PROFILES AND
CLINICAL VARIABLES
Preprocessing of the clinical data associated with the 142
images in the data set identified 14 clinical variables of interest.
(Variables with large numbers of missing values were excluded,
as were variables with constant values). Each variable was
cross-tabulated against each of the four profile features, or
correlation coefficients were calculated, or a MANOVA was
performed. Where the clinical variable was a binary categorical
variable, t-tests were used to compare the mean value of the
profile variable by clinical group. For example, metastasis was
grouped by value as “M0” or “M1” and it was natural to
compare the average numbers of different types of cells in the
two groups.
Table 4 shows the six clinical variables for which the
(uncorrected) t-test had a p ≤ 0.05 for at least one of the four
cell types. The other clinical variables were also tested, but no
significant relationships were observed and we do not show
these results. Table 4 shows the name of the clinical variable
in the first column followed by the categories of interest and
the number of patients in each category. In lines containing
cell types, the average value of the cell count is shown for
each category, followed by the p-value. The significance value
of 0.05, appropriate to a single test has been adjusted using the
Benjamini-Hochberg correction (Hochberg and Benjamini, 1990;
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Benjamini and Hochberg, 1995) and is shown in the column
labeled “BH p-value.”
Differences between the two categories for metastasis had
significant p-values for all cell types. Compared with M0
(colorectal cancer without evidence of distant metastasis), the
category M1, where metastasis was present, had increased
numbers of fibroblasts and “Other” cells and fewer epithelial
cells and inflammatory cells. The presence of residual tumor
was also associated with more fibroblasts and “Other” cells
and fewer epithelial cells and inflammatory cells. Both vascular
invasion and venous invasion were associated with increased
numbers of fibroblasts. Venous invasion was associated with
fewer epithelial cells.
Mucinous carcinomas were associated with fewer
inflammatory cells than were non-mucinous carcinomas.
Finally, the 12 patients who were recorded as dead when
added to the TCGA repository were also likely to have
fewer inflammatory cells detected than patients who were
recorded as alive, although the associated p-values were
not significant.
TABLE 3 | Correlation matrix of cell counts.
Epithelial Inflammatory Fibroblast Other
Epithelial 1
Inflammatory 0.20 1
Fibroblast −0.59 −0.34 1
Other −0.63 −0.13 0.56 1
Epithelial Inflammatory Fibroblast Other
Note that the remaining clinical variables, for which no
associations were found, were as follows: Gender, Age, T Stage,
N Stage, History of colon polyps, History of other malignancy,
Anatomic neoplasm subdivision (Tumor Location—left side vs.
right side), and CEA level.
DISCUSSION
Conclusions
In this application statistical sampling of patches from whole-
slides images proved to be worthwhile: significant improvements
in performance were achieved with very little loss of accuracy.
Systematic random sampling was markedly more accurate than
straightforward random sampling. For example, with a sample
size of 100, and considering epithelial cell counts the batch
difference indicator was 3.5% for systematic random sampling
and 5.8% for basic random sampling (Table 3 above).
The profiles being computed were particularly suitable for
random sampling because the features of interest were additive
over regions in the images. In applications where the regions of
interest are sparse and spatially concentrated, adaptive sampling
may be more appropriate. The two examples from the literature,
discussed in the introduction use random sampling to find
regions of interest followed by adaptive sampling to narrow
the search.
Statistically significant associations between morphology and
various clinical variables were found in this study. The TNM
grading system used in cancer treatment considers tumor
penetration, nodes, and metastasis (National Cancer Institute,
2018). Of these three indicators significant associations were
found for metastasis, for all four types of cell.
TABLE 4 | Associations between cells counts and clinical variables.
Clinical variable p-value BH p-value BH sig
Metastasis M0 (n = 120) M1 (n = 21)
Epithelial 22.1 17.2 0.00152 0.0411 Y
Inflammatory 5.8 4.0 0.0372 0.0411 Y
Fibroblast 5.3 7.7 0.0156 0.0429 Y
Other 2.1 3.5 0.00506 0.0482 Y
Residual tumor R0 (n = 117) R2 (n = 20)
Epithelial 22.1 17.7 0.0130 0.0438 Y
Inflammatory 5.8 4.4 0.0506 0.0393 N
Fibroblast 5.3 7.8 0.0179 0.0420 Y
Other 2.2 3.3 0.0100 0.0464 Y
Vascular invasion NO (n = 64) YES (n = 73)
Fibroblast 4.6 6.4 0.00661 0.0473 y
Venous invasion NO (n = 98) YES (n = 30)
Epithelial 22.9 19.4 0.0111 0.0455 Y
Fibroblast 4.8 6.4 0.0116 0.0446 Y
Mucinous carcinoma NO (n = 120) YES (n = 20)
Inflammatory 5.9 3.4 0.00361 0.0491 Y
Vital status Alive (n = 130) Dead (n = 12)
Inflammatory 5.70 3.80 0.0488 0.0402 N
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There were five clinical variables for which we found
significant relationships with morphological features. Four
clinical variables had significant associations with fibroblast
counts: in each case higher fibroblast counts were associated with
poorer values of the clinical variable. This is not unexpected
(Hewitt et al., 1993). In a review of the role of cancer-associated
fibroblasts in the tumor microenvironment, Kalluri (2016) refers
to fibroblasts as the “cockroaches” of the human body and
states that they play an important role in tumorigenesis and
cancer progression.
Two clinical variables were associated with differences in
inflammatory cell counts, namely metastasis, and mucinous
carcinoma. Poor values of the clinical variables were associated
with lower numbers of inflammatory cells, which might be
expected, in the light of the positive role of tumor infiltrating
lymphocytes in slowing down disease progression (Nosho et al.,
2010; Nigro et al., 2016).
Finally, metastasis, residual tumor, and venous invasion were
related to lower numbers of epithelial cells.
The morphological features extracted from the 142 diagnostic
images from the COAD data set may be regarded as expressions
of cellularity. Cellularity is a familiar concept in pathology: here
each morphological feature corresponds to the spatial density of
the corresponding cell type.
Future Directions
In addition to the cellularity features studied here, other features
may be calculated using deep learning. Such features include
tumor budding which is the presence of single tumor cells or small
clusters of up to five cells in the stroma and which is associated
with aggressive cancer (Ueno et al., 2002; De Smedt et al.,
2016; Koelzer et al., 2016). In addition, (Konishi, 2018)suggest
that poorly differentiated clusters, perineural invasion, and
desmoplastic reaction are also important in diagnosis. Another
morphology of interest is that of serrated cancers in which the
colonic glands are of distinctly serrated form (García-Solano
et al., 2012; Murcia et al., 2016).
Jass (2007) classified colorectal cancers according tomolecular
features, observing that they are related to morphological
features such as the number of tumor infiltrating lymphocytes,
differentiation, presence of dirty necrosis, serration, tumor
budding, mucinous/not mucinous, and presence of an expanding
invasive margin. Felipe De Sousa et al. (2013) reported that
serrated cancers have distinct molecular features. Deep learning
has recently been used to predict diagnostic molecular features
frommorphology, e.g., for lung cancer (Coudray et al., 2018), and
breast cancer (Couture et al., 2018). It is to be expected that future
work with deep learning will enable morphological, clinical and
molecular data to be linked.
Extending the Analysis
We have shown experimentally that a cell identification
algorithm using deep learning can uncover interesting
relationships between tissue morphology and a range of
clinical variables and that systematic sampling of tissue regions
can improve performance without losing accuracy.
The experimental results in this paper were obtained from
a single TCGA site. The analysis should be extended to all
sites in the TCGA colon cancer repository. In the experiments
carried out here, standardization was straightforward, using the
pooled average intensities of a group of WSIs to normalize data.
Unfortunately, there is no guarantee that this approach will
always be successful. Standardization techniques that cater for
the many different originating sites in TCGA should be used.
Carried out effectively, standardization ensures that reproducible
morphological features are generated.
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